Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19
Topu Raihan, Muhammad Fazle Rabbee, Puja Roy, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Secondary Metabolites Produced by Plant Growth-Promoting Bacterial Endophytes
Zareen Narayanan, Bernard R. Glick
Microorganisms (2022) Vol. 10, Iss. 10, pp. 2008-2008
Open Access | Times Cited: 61
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Fatma A. Moharram, Reham R. Ibrahim, Shahenda Mahgoub, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313616-e0313616
Open Access
Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses
Linda Sukmarini
Molecules (2022) Vol. 27, Iss. 9, pp. 2619-2619
Open Access | Times Cited: 31
High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein
Mark Andrian B. Macalalad, Nyzar Mabeth O. Odchimar, Fredmoore L. Orosco
Computational Biology and Chemistry (2024) Vol. 112, pp. 108133-108133
Closed Access | Times Cited: 4
Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future
Zdeněk Dvořák, Hao Li, Sridhar Mani
Drug Metabolism and Disposition (2022) Vol. 51, Iss. 2, pp. 219-227
Open Access | Times Cited: 13
Phytochemicals in antiviral drug development against human respiratory viruses
Surya Kant Mehta, Ran Bahadur Pradhan
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104107-104107
Closed Access | Times Cited: 1
Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome
Alexander Bontempo, Alexandra Chirino, Alireza Heidari, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 1
Anthracyclines inhibit SARS-CoV-2 infection
Zhen Wang, Qinghua Pan, Ling Ma, et al.
Virus Research (2023) Vol. 334, pp. 199164-199164
Open Access | Times Cited: 4
Galdieria sulphuraria: An Extremophilic Alga as a Source of Antiviral Bioactive Compounds
Annalisa Ambrosino, Annalisa Chianese, Carla Zannella, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 383-383
Open Access | Times Cited: 4
Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery
Hassan Zafar, Milton H. Saier
Cells (2023) Vol. 12, Iss. 9, pp. 1213-1213
Open Access | Times Cited: 2
Lavandula austroapennina: Assessment of the Antiviral Activity of Lipophilic Extracts from Its Organs
Annalisa Chianese, Claudia Gravina, Maria Vittoria Morone, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1648-1648
Open Access | Times Cited: 2
Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms
Faezeh Almasi, Wen Dang, Fatemeh Mohammadipanah, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 12, pp. 909-937
Open Access | Times Cited: 4
Inhibition of SARS-CoV-2 infection byPorphyromonas gingivalisand the oral microbiome
Alexander Bontempo, Alexandra Chirino, Alireza Heidari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anti-influenza activity of CPAVM1 protease secreted by Bacillus subtilis LjM2
Juan Li, Hong Cui, Yujie Yao, et al.
Antiviral Research (2024) Vol. 228, pp. 105919-105919
Closed Access
Evaluating microbial products as potential SARS-CoV-2 inhibitors
Shreynish Joy Mawooa, Hema Bikoo, Yojna Chumrah, et al.
Elsevier eBooks (2024), pp. 265-295
Closed Access
Natural Product-Based Anti-Viral Agents Against RNA Viruses: An Important Strategy for Pandemic Preparedness
Thrithamarassery Gangadharan Nandu, Jithesh Kottur
(2024), pp. 411-440
Closed Access
Natural Products: Exploring Potential Against SARS CoV2
Preetha Nair, Sabu Abdulhameed
(2024), pp. 441-474
Closed Access
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization
Wenbin Yu, Xiang Wei, Yichuan Wu, et al.
Critical Reviews in Microbiology (2024), pp. 1-19
Closed Access
Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches
Hourieh Kalhor, Mohammad Hossein Mokhtarian, Hamzeh Rahimi, et al.
Deleted Journal (2024) Vol. 23, Iss. 1
Open Access
Metabolomics in clinical diagnosis, prognosis, and treatment of infectious diseases
Abul Kalam Azad, Al Hakim, Md. Mehadi Hasan Sohag, et al.
Elsevier eBooks (2023), pp. 71-119
Closed Access | Times Cited: 1
Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery
Hassan Zafar, Milton H. Saier
(2023)
Open Access | Times Cited: 1
Antimicrobial and Cytotoxic Naphthoquinones from Microbial Origin: An Updated Review
Marziyeh Esmaeilzadeh Kashi, Mahdiyeh Ghorbani, Hasan Badibostan, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 8, pp. 844-862
Open Access | Times Cited: 1
Therapeutic Drug Targets for Covid-19
Şuayib Yalçın
Virology & Immunology Journal (2023) Vol. 7, Iss. 3, pp. 1-10
Open Access | Times Cited: 1
Editorial: Metabolomics in Infectious Diseases
Mahbuba Rahman, Herb E. Schellhorn, Puthen V. Jithesh, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 2
Selected lipopeptides of Bacillus as plausible inhibitors of SARS-COV-2 chymotrypsin-like protease 3CLPro: an in-silico analysis
S. P. Sen, Saikat Banerjee, Atreyee Ghosh, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top